Market Herald Powerplay host Dave Jackson interviews Christopher J. Moreau CEO of Algernon Pharmaceuticals in regards to the Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Chronic Cough Phase 2 Study.
Market Herald Powerplay host Dave Jackson interviews Christopher J. Moreau CEO of Algernon Pharmaceuticals in regards to the Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Chronic Cough Phase 2 Study.